Douglas Brown

2.1k total citations · 1 hit paper
29 papers, 1.8k citations indexed

About

Douglas Brown is a scholar working on Molecular Biology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Douglas Brown has authored 29 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Douglas Brown's work include Heat shock proteins research (5 papers), Protein Structure and Dynamics (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Douglas Brown is often cited by papers focused on Heat shock proteins research (5 papers), Protein Structure and Dynamics (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Douglas Brown collaborates with scholars based in United States and United Kingdom. Douglas Brown's co-authors include Erwin London, Rolf Schroeder, Gerald L. Waneck, John L. Middlebrook, Ranjan Banerjee, Eranthie Weerapana, Brian S. J. Blagg, George Vielhauer, Jeffrey M. Holzbeierlein and Huiping Zhao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Douglas Brown

29 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior.

1994 592 citations Rolf Schroeder, Erwin London et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas Brown United States	20	1.1k	348	213	188	174	29	1.8k
Jinhua Wang United States	29	1.4k 1.3×	206 0.6×	234 1.1×	186 1.0×	80 0.5×	76	2.4k
Tomoko Nakayama Japan	17	1.7k 1.5×	658 1.9×	206 1.0×	109 0.6×	115 0.7×	45	2.6k
Thomas Bock Switzerland	20	1.1k 1.0×	190 0.5×	139 0.7×	46 0.2×	149 0.9×	28	2.0k
Shizuo Handa Japan	26	1.5k 1.3×	320 0.9×	323 1.5×	330 1.8×	290 1.7×	81	2.3k
Reika Watanabe Japan	25	1.5k 1.3×	824 2.4×	230 1.1×	132 0.7×	417 2.4×	45	2.5k
Kazuki Nakajima Japan	22	1.0k 0.9×	194 0.6×	357 1.7×	343 1.8×	118 0.7×	60	1.4k
Brian R. Cannon United States	11	1.7k 1.5×	83 0.2×	374 1.8×	110 0.6×	141 0.8×	11	2.1k
Jiahai Shi Hong Kong	27	2.0k 1.7×	145 0.4×	224 1.1×	84 0.4×	259 1.5×	78	2.9k
Evangelia Livaniou Greece	25	612 0.5×	291 0.8×	191 0.9×	134 0.7×	93 0.5×	87	1.6k
Arnaud Leroy France	23	1.0k 0.9×	255 0.7×	194 0.9×	78 0.4×	529 3.0×	38	1.6k

Countries citing papers authored by Douglas Brown

Since Specialization

Citations

This map shows the geographic impact of Douglas Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Brown more than expected).

Fields of papers citing papers by Douglas Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Brown. The network helps show where Douglas Brown may publish in the future.

Co-authorship network of co-authors of Douglas Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Brown. A scholar is included among the top collaborators of Douglas Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Brown. Douglas Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Castillo, Carlos Fernández‐del, Douglas Brown, Mari Mino–Kenudson, et al.. (2023). Impact of preoperative endoscopic procedures on adverse event rates after surgical resection for main-duct and mixed-type intraductal papillary mucinous neoplasms (IPMNs). Pancreatology. 24(1). 152–159. 1 indexed citations

Hu, Guangan, Yang Su, Byong H. Kang, et al.. (2021). High-throughput phenotypic screen and transcriptional analysis identify new compounds and targets for macrophage reprogramming. Nature Communications. 12(1). 773–773. 101 indexed citations

Li, Yingzhong, Nikola A. Ivica, Ting Dong, et al.. (2020). MFSD7C switches mitochondrial ATP synthesis to thermogenesis in response to heme. Nature Communications. 11(1). 4837–4837. 32 indexed citations

Xie, Guozhu, Nikola A. Ivica, Bin Jia, et al.. (2020). CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia. Nature Biomedical Engineering. 5(5). 399–413. 58 indexed citations

Liu, Weiya, George Vielhauer, Jeffrey M. Holzbeierlein, et al.. (2015). KU675, a Concomitant Heat-Shock Protein Inhibitor of Hsp90 and Hsc70 that Manifests Isoform Selectivity for Hsp90α in Prostate Cancer Cells. Molecular Pharmacology. 88(1). 121–130. 33 indexed citations

Kusuma, Bhaskar Reddy, Anuj Khandelwal, Douglas Brown, et al.. (2014). Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors. Bioorganic & Medicinal Chemistry. 22(4). 1441–1449. 46 indexed citations

Brown, Douglas, Huiping Zhao, Bhaskar Reddy Kusuma, et al.. (2013). Development of a High-Throughput Screening Cancer Cell-Based Luciferase Refolding Assay for Identifying Hsp90 Inhibitors. Assay and Drug Development Technologies. 11(8). 478–488. 12 indexed citations

Banerjee, Ranjan, Nicholas J. Pace, Douglas Brown, & Eranthie Weerapana. (2013). 1,3,5-Triazine as a Modular Scaffold for Covalent Inhibitors with Streamlined Target Identification. Journal of the American Chemical Society. 135(7). 2497–2500. 88 indexed citations

Weerapana, Eranthie, Ranjan Banerjee, & Douglas Brown. (2013). Recent Developments in the Synthesis of Bioactive 2,4,6-Trisubstituted 1,3,5-Triazines. Synlett. 24(13). 1599–1605. 20 indexed citations

10.

Zhao, Huiping, Alison C. Donnelly, Bhaskar Reddy Kusuma, et al.. (2011). Engineering an Antibiotic to Fight Cancer: Optimization of the Novobiocin Scaffold to Produce Anti-proliferative Agents. Journal of Medicinal Chemistry. 54(11). 3839–3853. 147 indexed citations

11.

Kazanjian, Avedis, Taeko K. Noah, Douglas Brown, Jarred Burkart, & Noah F. Shroyer. (2010). Atonal Homolog 1 Is Required for Growth and Differentiation Effects of Notch/γ-Secretase Inhibitors on Normal and Cancerous Intestinal Epithelial Cells. Gastroenterology. 139(3). 918–928.e6. 70 indexed citations

12.

Kazanjian, Avedis, Taeko K. Noah, Douglas Brown, Jarred Burkart, & Noah F. Shroyer. (2010). 268 Atonal Homolog 1 (ATOH1) is Essential for Growth and Differentiation Effects of Notch/γ Secretase Inhibitors on Normal and Cancerous Intestinal Epithelial Cells. Gastroenterology. 138(5). S–50. 2 indexed citations

13.

Smith, Leonard A., et al.. (2004). Roads from vaccines to therapies. Movement Disorders. 19(S8). S48–S52. 24 indexed citations

14.

Brown, Douglas, et al.. (2000). Pentoxifylline fails to improve organ dysfunction and survival when used in the resuscitation of a porcine model of haemorrhage and abdominal sepsis. Resuscitation. 44(1). 61–69. 5 indexed citations

15.

Brown, Douglas, et al.. (2000). A PORCINE MODEL OF SEPSIS RESULTING FROM THE COMBINED INSULTS OF HEMORRHAGE AND PERITONITIS. Shock. 13(4). 291–296. 12 indexed citations

16.

Brown, Douglas, et al.. (1997). Identification and Characterization of a Neutralizing Monoclonal Antibody Against Botulinum Neurotoxin, Serotype F, Following Vaccination With Active Toxin. Hybridoma. 16(5). 447–456. 15 indexed citations

17.

Brown, Douglas, et al.. (1995). Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli. Infection and Immunity. 63(7). 2738–2742. 129 indexed citations

18.

Schroeder, Rolf, Erwin London, & Douglas Brown. (1994). Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior.. Proceedings of the National Academy of Sciences. 91(25). 12130–12134. 592 indexed citations breakdown →

19.

Brown, Douglas & C D Parker. (1987). Cloning of the filamentous hemagglutinin of Bordetella pertussis and its expression in Escherichia coli. Infection and Immunity. 55(1). 154–161. 27 indexed citations

20.

Brown, Douglas & John H. Growdon. (1980). l-Tryptophan administration potentiates serotonin-dependent myoclonic behavior in the rat. Neuropharmacology. 19(4). 343–347. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact